Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-adrenoreceptor subtype expression in human liver.

P Arner1, P Engfeldt, L Hellström

  • 1Department of Medicine, Huddinge Hospital, Sweden.

The Journal of Clinical Endocrinology and Metabolism
|November 1, 1990
PubMed
Summary

Human liver expresses beta-2 adrenoceptors (BAR2) but not beta-1 adrenoceptors (BAR1). This is due to a posttranscriptional block, despite higher BAR1 mRNA levels, indicating unique gene regulation in liver tissue.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Waist circumference to assess reversal of insulin resistance following weight reduction after bariatric surgery: cohort and cross-sectional studies.

International journal of obesity (2005)·2013
Same author

Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity.

Diabetologia·2010
Same author

Beta3-adrenoceptor function and long-term changes in body weight.

International journal of obesity (2005)·2009
Same author

The role of adrenal scintigraphy in the preoperative management of primary aldosteronism.

Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society·2008
Same author

Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue.

Diabetologia·2007
Same author

Oestrogen receptor alpha gene expression levels are reduced in obese compared to normal weight females.

International journal of obesity (2005)·2007

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Human Physiology

Background:

  • Beta-1 and beta-2 adrenoceptors (BAR1, BAR2) are crucial for regulating various physiological processes.
  • Understanding the expression and regulation of these receptor subtypes in specific human tissues like the liver is vital for targeted therapeutic strategies.

Purpose of the Study:

  • To investigate the pharmacological presence and gene expression of BAR1 and BAR2 in human liver.
  • To elucidate the relationship between adrenoceptor binding sites and mRNA levels for these subtypes.
  • To determine the regulatory mechanisms governing BAR subtype expression in the human liver.

Main Methods:

  • Radioligand binding assays using [125I]Cyanopinodolol.
  • Adenylate cyclase activity experiments with adrenergic agents.

Related Experiment Videos

  • RNA excess solution hybridization and Northern blot analysis for mRNA quantification and characterization.
  • Assessment of mRNA stability through half-life determination.

    • Main Results:

    • Human liver plasma membranes and microsomes exclusively contain BAR2 binding sites.
    • Adenylate cyclase activity in liver membranes indicates a specific BAR2-mediated response.
    • Northern blot analysis revealed distinct mRNA sizes for BAR1 (2.5-2.6 kb) and BAR2 (2.2-2.3 kb).
    • Solution hybridization showed BAR1 mRNA levels were 5-fold higher than BAR2 mRNA.
    • mRNA stability for both subtypes was similar, with a half-life of approximately 5.5 hours.

    Conclusions:

    • Human liver expresses only BAR2, despite higher basal BAR1 mRNA levels.
    • A posttranscriptional regulatory mechanism appears to block basal BAR1 expression in the liver.
    • Specific factors likely control the steady-state expression of adrenoceptor subtypes in human liver, leading to tissue-specific receptor profiles.